ABSTRACT:
A rapid and simple method of spectrophotometric estimation Empagliflozin in UV-region was developed and validated according to International Conference on Harmonization (ICH Q2 R1) guidelines. The standard and sample solutions were prepared using ethanol and water. The maximum absorbance (?max) was obtained at 223 nm. The calibration curve was linear in the range of 1-30µg/ml. The %RSD for intra and inter-day precision was found to be 0.29 and 0.39 respectively. Recovery studies of Empagliflozin were within 99.20% to 99.49 and assay was found to be 99.87% and LOD and LOQ was found to be 0.10 and 0.33 respectively. The %RSD for robustness was found to be between 0.20 and %RSD for ruggedness was found to be 0.03. The proposed method was found to be rapid, precise, accurate and can be adaptable for routine analysis of Empagliflozin bulk and marketed dosage forms.
Cite this article:
Shaik Bima Benazir, Jorige Archana, Mogili Sumakanth. Method Development and Validation of Empagliflozin in Bulk and Pharmaceutical Dosage Form using UV Spectroscopy. Asian Journal of Pharmaceutical Analysis. 2021; 11(2):123-6. doi: 10.52711/2231-5675.2021.00021
Cite(Electronic):
Shaik Bima Benazir, Jorige Archana, Mogili Sumakanth. Method Development and Validation of Empagliflozin in Bulk and Pharmaceutical Dosage Form using UV Spectroscopy. Asian Journal of Pharmaceutical Analysis. 2021; 11(2):123-6. doi: 10.52711/2231-5675.2021.00021 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2021-11-2-11
REFERENCES:
1. Nachiket S et al. Simultaneous Estimation, Validation and Force Degradation Study of Metformin Hydrochloride and Empagliflozin by RP-HPLC Method. Research Journal of Science and Technology. 2019; 11(2):135-147.
2. Sushil D et al. Development and validation of UV spectrophotometric method for Simultaneous estimation of Empagliflozin and Metformin hydrochloride in bulk drugs. Asian Journal of Pharmaceutical Analysis. 2017; 7(2): 117-123.
3. Patil PM et al. Direct Spectrophotometeric Determination of Metformin Hydrochloride in Pure Form and in Pharmaceutical Formulations. Research Journal of Pharmacy and Technology. 2009; 2 (4): 874-875.
4. Gupta A et al. Glitazones for the Treatment of Diabetes Type-2. Asian Journal of Research in Chemistry. 2012; 5(2): 164-170.
5. Sujatha Kumari M et al. Diabetes Mellitus: Present status and Drug therapy Updates. Research Journal of Pharmacy and Technology. 2014; 7(1): 84-94.
6. Syed Irfan Ali et al. Stability Indicating Simultaneous Estimation of Metformin and Empagliflozin in Pharmaceutical Tablet Dosage form by RP-HPLC. Asian Journal of Research in Chemistry. 2017; 10(6): 783-788.
7. Sushil D et al. Development and Validation of RP- HPLC Method for Estimation of Empagliflozin and its Stability Studies In vitro Simulated Gastric and Intestinal Fluids. Asian Journal of Pharmaceutical Analysis. 2019; 9(3): 156-160.
8. Naga Ravi Kiran T et al. Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Linagliptin, Empagliflozin and Metformin in Solid Dosage Forms. Asian Journal of Pharmaceutical Analysis. 2020; 10(3): 117-124.
9. Hazaratali Panari, Vegunarani M. Study on Complications of Diabetes Mellitus among the Diabetic Patients. Asian Journal of Nursing Education and Research. 2016; 6(2): 171-182.
10. Ganesh Shinde et al. Review on Advances in UV Spectroscopy. Research Journal of Science and Technology. 2020; 12(1): 47-51.